Treating long COVID symptoms
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
There is no approved treatment for long COVID as a whole, and anyone claiming otherwise is selling something. Trials of several candidates are running.
That is not the same as nothing being available. Several of the individual symptoms have established treatments, and that is where the realistic gains are.
Related pages: Long COVID · Chronic fatigue syndrome (ME/CFS)
The bottom line
- No treatment is approved for long COVID as a whole.
- Several individual symptoms have established treatments.
- Smell training has reasonable evidence for smell loss.
- Several heavily marketed treatments are unproven or harmful.
- Which treatments under trial will prove effective.
- Whether any single mechanism explains enough of long COVID to be targeted.
The story, step by step
- 1. What is treatable ()
- 2. Smell training ()
- 3. Under investigation ()
- 4. What to avoid ()
- 5. The realistic picture ()
What the evidence labels mean
Symptom by symptom
What happens
The parts where treatment genuinely exists.
What the research shows
- Orthostatic symptoms and POTS: fluids, salt where safe, compression, and medications including beta blockers, ivabradine, midodrine and fludrocortisone.
- Sleep: treating sleep apnoea, and addressing insomnia, which is common and responds to cognitive behavioural approaches.
- Pain and headaches: standard approaches including medications used for nerve pain where that fits.
- Mast cell symptoms, where flushing, hives and food or smell reactions dominate: antihistamines and related treatments, typically specialist-directed.
- Depression and anxiety: treatable, worth treating, and treating them improves function without implying the illness is psychological.
- Breathing pattern disorder: breathing retraining with a physiotherapist, once cardiac and lung causes have been excluded.
Why it matters
The gains here are real but piecemeal. Listing symptoms in order of impact is what gets the treatable ones addressed.
What's still uncertain
- Most of this is extrapolated from other conditions rather than tested in long COVID.
Read more
- CDC: Long COVIDGovernment
- OwieClear: POTS (postural orthostatic tachycardia syndrome)OwieClear
Next: Smell training
A real intervention
What happens
One of the few long COVID-specific treatments with supporting evidence.
What the research shows
- Smell training involves sniffing a set of distinct scents, classically rose, lemon, clove and eucalyptus, twice daily for several months.
- Each is sniffed for around 20 seconds while concentrating on the memory of that smell.
- Trials in post-viral smell loss show modest benefit, and it has essentially no risk and very low cost.
- It takes months rather than weeks, and stopping early is the usual reason it does not work.
- Parosmia, where familiar smells become unpleasant or revolting, is distressing and often improves over time. It is a sign of nerve regeneration rather than deterioration.
- Steroid nasal sprays are sometimes used where there is also nasal inflammation.
Why it matters
If smell loss is the problem, this is worth starting now. It is cheap, safe, and the main failure mode is stopping too soon.
What's still uncertain
- Effect sizes are modest and trials are mostly small.
Read more
- CDC: Long COVIDGovernment
- MedlinePlus: Long COVIDGovernment
Next: Under investigation
What is being trialled
What happens
Candidate treatments being tested, none yet established.
What the research shows
- Extended antiviral courses, on the hypothesis that virus persists in tissue. Trials have reported mixed and largely disappointing results so far.
- Immune-modulating treatments and anti-inflammatory approaches.
- Drugs targeting autonomic dysfunction and blood flow.
- Metformin, which reduced long COVID incidence when given during acute infection in one trial, is being studied further. That is prevention during acute illness, not treatment of established long COVID.
- Large publicly funded programmes are running trials across several of these.
- Joining a trial is a legitimate option and is different from paying a clinic for an unproven treatment.
Why it matters
The distinction worth holding: a trial that measures outcomes and publishes them, versus a clinic that charges for the same idea without doing either.
What's still uncertain
- Most candidate treatments will not prove effective.
Read more
- NIH RECOVER: Researching COVID to enhance recoveryGovernment
- OwieClear: What the long COVID treatment research actually showsOwieClear
Next: What to avoid
Unproven and harmful
What happens
The marketplace that has grown around long COVID.
What the research shows
- Blood washing, or apheresis, sometimes combined with anticoagulant drugs, is offered privately at high cost on the microclot hypothesis. It has not been shown to work, and combining anticoagulation with an unmonitored protocol carries a real risk of serious bleeding.
- Ivermectin has been tested for COVID and does not work, and there is no evidence for it in long COVID.
- Hyperbaric oxygen has small studies with mixed results, is expensive, and is not established treatment.
- Unregulated stem cell clinics sell infusions for long COVID without evidence.
- Extensive supplement protocols and intravenous vitamin drips, which have no trial support for long COVID.
- The pattern to watch for: a single explanatory mechanism, a treatment available only privately, payment in advance, testimonials instead of published results, and discouragement from asking your own doctor.
Why it matters
The reliable harm is not only the money. It is the time and the investigation that does not happen while an unproven protocol is running.
What's still uncertain
- Absence of evidence is not proof these do nothing, and none has shown benefit.
Read more
- FDA: Beware of fraudulent COVID-19 productsGovernment
- NIH RECOVER: Researching COVID to enhance recoveryGovernment
Next: The realistic picture
What to expect
What happens
Where things stand, honestly.
What the research shows
- Many people improve over months to years, and improvement is usually gradual and uneven rather than a clear recovery point.
- Some people recover fully. Some are left with a reduced baseline. Some remain severely affected, and that group is the least well served.
- Pacing, treating the treatable symptoms, and avoiding crashes is the approach with the most support, which is unsatisfying and is the current state.
- Reinfection can set recovery back, which is one of the few arguments for ongoing precautions that applies specifically to this group.
- New or worsening symptoms deserve fresh assessment rather than being folded into the long COVID label, because other conditions still happen.
- If hopelessness becomes persistent, that deserves support in its own right. In the United States, the 988 Suicide and Crisis Lifeline can be called or texted.
Why it matters
Progress is measured in months. That is the honest timeframe, and planning around it is easier than waiting for a week that feels different.
What's still uncertain
- Long-term outcomes are still being followed and vary widely.
Read more
- CDC: Long COVIDGovernment
- MedlinePlus: DepressionGovernment